Amicus Therapeutics Inc (FOLD)
10.17
-0.37
(-3.51%)
USD |
NASDAQ |
Apr 25, 16:00
10.18
+0.01
(+0.10%)
After-Hours: 20:00
Amicus Therapeutics Price: 10.17 for April 25, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 10.40 | 10.47 | 10.02 | 10.17 | 3.991M |
Apr 24, 2024 | 10.71 | 10.78 | 10.50 | 10.54 | 1.821M |
Apr 23, 2024 | 10.82 | 10.93 | 10.68 | 10.71 | 5.091M |
Apr 22, 2024 | 10.70 | 10.91 | 10.66 | 10.82 | 4.621M |
Apr 19, 2024 | 10.27 | 10.66 | 10.24 | 10.61 | 2.888M |
Apr 18, 2024 | 10.56 | 10.59 | 10.32 | 10.33 | 1.726M |
Apr 17, 2024 | 10.61 | 10.66 | 10.48 | 10.55 | 3.013M |
Apr 16, 2024 | 10.61 | 10.72 | 10.48 | 10.56 | 2.800M |
Apr 15, 2024 | 10.66 | 10.81 | 10.59 | 10.66 | 2.751M |
Apr 12, 2024 | 11.07 | 11.07 | 10.56 | 10.68 | 2.248M |
Apr 11, 2024 | 11.33 | 11.41 | 11.15 | 11.22 | 1.693M |
Apr 10, 2024 | 11.36 | 11.46 | 11.14 | 11.27 | 2.453M |
Apr 09, 2024 | 11.60 | 11.77 | 11.49 | 11.75 | 2.083M |
Apr 08, 2024 | 11.69 | 11.82 | 11.50 | 11.60 | 1.542M |
Apr 05, 2024 | 11.37 | 11.78 | 11.21 | 11.72 | 2.738M |
Apr 04, 2024 | 11.43 | 11.61 | 11.38 | 11.46 | 2.991M |
Apr 03, 2024 | 11.28 | 11.42 | 11.11 | 11.37 | 4.269M |
Apr 02, 2024 | 11.53 | 11.53 | 11.35 | 11.37 | 2.058M |
Apr 01, 2024 | 11.70 | 11.77 | 11.51 | 11.75 | 2.455M |
Mar 28, 2024 | 11.87 | 11.93 | 11.48 | 11.78 | 2.476M |
Mar 27, 2024 | 11.51 | 11.87 | 11.32 | 11.86 | 2.527M |
Mar 26, 2024 | 11.54 | 11.74 | 11.32 | 11.43 | 1.946M |
Mar 25, 2024 | 11.55 | 11.69 | 11.44 | 11.54 | 1.343M |
Mar 22, 2024 | 11.72 | 11.76 | 11.44 | 11.53 | 1.751M |
Mar 21, 2024 | 12.08 | 12.24 | 11.66 | 11.69 | 2.188M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
6.23
Minimum
May 09 2022
24.89
Maximum
Dec 22 2020
11.83
Average
11.30
Median
May 01 2020
Price Benchmarks
TG Therapeutics Inc | 13.91 |
Geron Corp | 3.56 |
Vanda Pharmaceuticals Inc | 4.48 |
Fate Therapeutics Inc | 3.87 |
Editas Medicine Inc | 5.22 |
Price Related Metrics
PS Ratio | 7.516 |
Price to Book Value | 18.75 |
Earnings Yield | -5.01% |
Market Cap | 3.004B |